City
Epaper

Delhi HC refuses to put stay on Phase 2-3 clinical trials of Covaxin for 2-18 age group

By ANI | Updated: May 19, 2021 13:05 IST

The Delhi High Court on Wednesday refused to put an interim stay on Phase 2-3 clinical trials of Covaxin COVID-19 vaccine for the 2-18 age group.

Open in App

The Delhi High Court on Wednesday refused to put an interim stay on Phase 2-3 clinical trials of Covaxin COVID-19 vaccine for the 2-18 age group.

The Court has issued a notice to the Centre, Central Drugs Standard Control Organizations, and others on the petition sought for quashing of nod given to Bharat Biotech for phase 2/3 clinical trial of Covaxin for the age group 2-18 years.

The bench of Justice DN Patel and Justice Jyoti Singh, on Tuesday, sought response from all the respondents and refused to put an interim stay on the trial as prayed by the petitioner.

A Public Interest Litigation (PIL) was moved to the court, which sought to quash the Central government's notification, dated May 13, that accorded permission to conduct the Phase II/III clinical trial of Covaxin for 2-18 age group to its manufacturer, Bharat Biotec Ltd.

The petition had also sought direction from respondents to place on record the details of the 525 children who will be subjected to phase II/III clinical trial of the Whole Virion inactivated Coronavirus vaccine.

The petitioner, Sanjeev Kumar, also sought Court's direction to the state to criminally prosecute the persons involved in such trials, and the persons having authorised conduct of such trials in the event of any death or loss of peaceful and pleasant enjoyment of the life of any toddler or minor children.

The petition stated that the order which requires the conduct of Phase II/III clinical trial of Covaxin by the Bharat Biotec Ltd. on 525 healthy volunteers (very young children ranging from 2 years old to 18 years old) is "prima facie unlawful, arbitrary and against the settled principles of law and natural justice" because the term 'Volunteer' itself means 'A person who freely offers to do something'.

It further states that a person can offer to do anything only if he/she is capable of understanding the consequences of his/her act.

"In the present case, the subject matter of clinical trials being minors; even toddlers who, for the reason of their age only, are not capable of even speaking and understanding languages in a proper manner, and hence cannot be supposed to 'Volunteer' for the aforesaid clinical testing," read the plea.

The petitioner also stated that in case the contract for the alleged volunteers has been signed by their parents/legal guardians, even then the same is unlawful as the same is clearly not for the welfare of the said children.

"It is trite in law that nobody can enter into a contract, the execution of which could endanger the life of minors," read the plea.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Evotec A.G.Delhi High CourtSanjeev KumarJyoti SinghDelhi delhi high court
Open in App

Related Stories

NationalTMC MP Mahua Moitra Approaches Delhi High Court Against Ex-Boyfriend Over Custody of Pet Dog Henry

Entertainment‘Celebrities Aren’t Public Property’: Vivek Oberoi’s Lawyer Sana Raees Khan Hails HC Order Protecting His Personality Rights

NationalDelhi Demolition Drive: 5 Cops Injured After Clashes Erupt Over Bulldozer Action Near Faiz-e-Elahi Masjid

EntertainmentSuperstar NTR Secures Landmark Legal Protection for Personality Rights; Actor Thanks Delhi HC Court In Appreciation Post

BusinessAnil Ambani's Reliance Power and Reliance Infra Shares in Focus on Monday After Delhi HC Grants Major Relief in Union Bank Fraud Case

National Realted Stories

NationalCCEA approves investment for development of 1720 MW Kamala Hydroelectric project in Arunachal

NationalDefence Minister-led IGoM takes stock of India's readiness in view of evolving West Asia situation

National14.5 kg of IED recovered & neutralised in J&K's Shopian, averts major terror incident

NationalOver 23 lakh pilgrims paid obeisance at J&K's Shri Mata Vaishno Devi Shrine in 2026

NationalIAEA Director General praises India's major nuclear milestone at Kalpakkam